Apr 26, 2021
13:10
For every 10 shares held, investors received 13. The price per share adjusted from $194.50 to $149.62.
The split itself did not change the total investment value.
PharmaBlock Sciences (Nanjing), Inc. Class A (SZSE:300725) operates in the Miscellaneous commercial services industry.
PharmaBlock Sciences (Nanjing), Inc. Class A company overviewPharmaBlock Sciences (Nanjing), Inc. Class A's most recent stock split was on April 26, 2021. It was a 13-for-10 forward split, so shareholders received 13 shares for every 10 they held.
PharmaBlock Sciences (Nanjing), Inc. Class A (SZSE:300725) has split its stock 3 times: a 3-for-2 split on May 18, 2018, a 13-for-10 split on May 8, 2019, and a 13-for-10 split on April 26, 2021.
PharmaBlock Sciences (Nanjing), Inc. Class A has split its stock 3 times. This history records 3 forward splits between May 18, 2018 and April 26, 2021.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In PharmaBlock Sciences (Nanjing), Inc. Class A's 13-for-10 split on April 26, 2021, every 10 shares became 13 shares.
PharmaBlock Sciences (Nanjing), Inc. Class A has not announced a new split in our records. Its most recent split was on April 26, 2021, 5 years ago. Companies announce splits in advance, and any new SZSE:300725 split will appear on this page.
Already premium?